Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.

This research paper offers updated guidelines for preventing migraines in adults. A group of experts reviewed recent studies and evidence. They aimed to create clear recommendations for healthcare providers. The guidelines help doctors decide when to start preventive medications. They also guide which medications to choose based on individual patient needs. The recommendations consider various situations and populations. This includes specific advice for patients with unique health conditions. The review covers studies published up to June 6, 2024. It integrates evidence from multiple sources and principles of care. The goal is to improve migraine management through effective pharmacologic treatments. By following these guidelines, healthcare providers can make informed decisions. This will ultimately enhance patient care and reduce migraine frequency. The guidelines aim to support both clinicians and patients in managing migraines effectively. They provide a structured approach to migraine prevention based on the latest research. Clinical relevance: These updated guidelines will help clinicians choose the best migraine prevention strategies for their patients, leading to more effective treatment outcomes.